BiotaLife Healthcare
MedTech balancing human microbiota with patented solutions.
BiotaLife Healthcare is a MedTech company developing innovative medical devices that naturally balance human microbiota for health and wellbeing.
The company relies on a patented solution able to selectively nurture the ‘good bacteria”, restoring the microbiome balance and treating conditions including vaginal thrush, bacterial vaginosis and vaginal dryness.
The BiotaLife journey so far:
- 2024: company founded
- 2025: pitched the London Life Sciences Week academics showcase
Team
Dr Marco Morelli
CEO
Business leader with 10+ years of company management experience in healthtech and medical devices testing & certification. PhD in Applied Physics, Executive MBA.
Professor Paul Long
Chief Technology Officer
A microbiologist by training, Professor Long's research uses a combination of bioinformatics, lab and field studies to discover new medicines from nature, particularly from the marine environment.
David Philips
Senior Business Manager
David is a molecular geneticist and virologist by background and has worked managing and licensing intellectual property for over 20 years.
He has twice worked for the University of Oxford’s
technology transfer office, where he was involved in technologies as diverse as novel anti-cancer agents and software for medical imaging and scanning. He has also spent considerable time in industry, working for multinationals such as GlaxoSmithKline and Mercury Pharma, through to small university-based start-up companies.
David is responsible for commercialisation opportunities arising from the Institute of Child Health at Great Ormond Street Hospital, the UCL Cancer Institute and the Institute of Cardiovascular Science.